Milestone Scientific (MLSS) Stock Price, News & Analysis

Company Overview

Milestone Scientific Inc., a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments. Its products include CompuDent and STA Single Tooth Anesthesia System that are used for all dental procedures that require local anesthetic. In addition, the company offers CompuFlo, a computer-controlled drug delivery system for the painless delivery of drugs, anesthetics, and other medicaments, as well as for the aspiration of bodily fluids or previously injected substances, and disposable injection handpiece for the tactile control during the injection. Further, it provides CompuFlo Epidural, a computer-controlled anesthesia system for use in various medical applications. Additionally, the company offers company offers CompuMed for use in various medical procedures performed in plastic, hair restoration, and colorectal surgery, as well as podiatry, dermatology, orthopedics, and various other disciplines. Milestone Scientific Inc. was incorporated in 1989 and is headquartered in Roseland, New Jersey.

Key Stats

• Today's Range: $0.88 to $0.96
• 50-Day Range: $0.93 to $1.33
• 52-Week Range: $0.54 to $1.39
• Volume: 109,534 shs
• Average Volume: 174,182 shs
• Market Capitalization: $74.69 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $1.25
• Consensus Rating: Buy

MLSS Stock Analysis - Frequently Asked Questions

How have MLSS shares performed this year?

Milestone Scientific's stock was trading at $0.96 at the start of the year. Since then, MLSS stock has decreased by 0.1% and is now trading at $0.9589.
View the best growth stocks for 2025 here.

How were Milestone Scientific's earnings last quarter?

Milestone Scientific Inc. (NYSE:MLSS) issued its quarterly earnings data on Thursday, August, 15th. The company reported ($0.02) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.01) by $0.01. The business earned $1.85 million during the quarter. Milestone Scientific had a negative net margin of 52.01% and a negative trailing twelve-month return on equity of 60.26%.

Who are Milestone Scientific's major shareholders?

Top institutional shareholders of Milestone Scientific include Bridgeway Capital Management LLC (0.47%), Carnegie Investment Counsel (0.22%), Renaissance Technologies LLC (0.16%) and Concourse Financial Group Securities Inc.. Insiders that own company stock include Leonard Osser, Neal I Goldman, Michael Mcgeehan and Leslie Bernhard.
View institutional ownership trends.

How do I buy shares of Milestone Scientific?

Shares of MLSS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Milestone Scientific own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Milestone Scientific investors own include Waste Connections (WCN), DiamondRock Hospitality (DRH), The RMR Group (RMR), AUO (AUOTY), iShares Micro-Cap ETF (IWC), American Water Works (AWK) and Triple Flag Precious Metals (TFPM).

Company Calendar

• Last Earnings: 8/15/2024
• Today: 3/13/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Medical
• Industry: Surgical appliances & supplies
• Sub-Industry: Medical Equipment
• Current Symbol: NYSE:MLSS
• CIK: 855683
• Web: www.milestonescientific.com
• Phone: (973) 535-2717
• Fax: 973-535-2829
• Employees: 30
• Year Founded: N/A

Price Target and Rating

• Average Stock Price Target: $1.25
• High Stock Price Target: $1.25
• Low Stock Price Target: $1.25
• Potential Upside/Downside: +30.4%
• Consensus Rating: Buy
• Rating Score (0-4): 3.00
• Research Coverage: 1 Analysts

Profitability

• EPS (Most Recent Fiscal Year): ($0.07)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $-6,930,000.00
• Net Margins: -52.01%
• Pretax Margin: -52.21%
• Return on Equity: -60.26%
• Return on Assets: -40.23%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 2.85
• Quick Ratio: 1.86

Sales & Book Value

• Annual Sales: $8.88 million
• Price / Sales: 8.41
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $0.11 per share
• Price / Book: 8.72

Miscellaneous

• Outstanding Shares: 77,892,000
• Free Float: 58,614,000
• Market Cap: $74.69 million
• Optionable: Optionable
• Beta: 1.41